The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke


Phase 3 Results N/A

Eligibility Criteria

Inclusion Criteria

- stroke affecting one body side
- spasticity develops after stroke

Exclusion Criteria

- musculoskeletal conditions that affected upper limb function prior to stroke
- concurrent use of anti-spasticity medications
- patients with neuromuscular junction or myopathic disorders such as myasthenia gravis or others
- patients with a known allergy to any onabotulinumtoxinA or to any of the excipients of onabotulinumtoxinA (such as human serum albumin)
- patients who are pregnant or may become pregnant at the time of the proposed injection